文献速递角膜与眼表疾病眼整形与眼眶

睑板腺功能障碍:驱动眼表炎症损伤恶性循环的眼部移植物抗宿主病进展途径

Meibomian Gland Dysfunction: A Route of Ocular Graft-Versus-Host Disease Progression That Drives a Vicious Cycle of Ocular Surface Inflammatory Damage.
PubMed 文献 · Am J Ophthalmol · 2022-09-23

研究在小鼠同种异体GVHD模型中证实全身性T细胞依赖过程导致睑板腺损伤并加重视眼表病变,BM+T小鼠较BM-only小鼠全身疾病评分更高且与泪液减少和眼睑水肿相关;回顾性分析57例眼部GVHD患者中96%有其他器官受累、MMP-9阳性率92%,MGD萎缩程度越高眼表病变体征越重。

要点

  • BM+T小鼠全身疾病评分高于BM-only,且与泪液减少和眼睑水肿相关。
  • BM+T小鼠眼组织免疫细胞浸润及引流淋巴结CD4+细胞因子表达增高。
  • 57例眼部GVHD患者中96%有其他器官受累,MMP-9阳性率92%。

核心结论

  • 眼部GVHD由全身性T细胞依赖过程驱动,该过程导致睑板腺损伤并诱发与MGD严重程度相关的强烈眼表疾病。

研究设计与样本

  • 小鼠实验:将C57BL/6J小鼠骨髓和纯化脾T细胞转移至受照射C3-SW.H2b小鼠建立同种异体GVHD模型(BM+T),对照组仅接受骨髓(BM only)。
  • 人类部分:回顾性分析57例就诊于Duke Eye Center的眼部GVHD患者,睑板腺功能障碍按睑板腺成像萎缩程度分级。

主要发现

  • BM+T小鼠较BM-only小鼠全身疾病评分更高,且与泪液减少和眼睑水肿相关。
  • BM+T小鼠眼组织免疫细胞浸润更高,引流淋巴结CD4+细胞因子表达更高。
  • MGD评分更差的BM+T小鼠角膜染色显著更差。
  • 眼部GVHD患者中96%有其他器官受累,干眼检查参数异常,MMP-9阳性率92%,泪液样本免疫细胞丰富。
  • MGD严重程度评分更高的患者眼表疾病体征更重。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the role of aggressive meibomian gland dysfunction (MGD) in the immune pathogenesis of ocular graft-vs-host disease (GVHD). METHODS: In mice, an allogeneic GVHD model was established by transferring bone marrow (BM) and purified splenic T cells from C57BL/6J mice into irradiated C3-SW.H2b mice (BM+T). Control groups received BM only. Mice were scored clinically across the post-transplantation period. MGD severity was categorized using the degree of atrophy on harvested lids. Immune disease was analyzed using flow cytometry of tissues along with fluorescent tracking of BM cells onto the ocular surface. In humans, parameters from 57 patients with ocular GVHD presenting to the Duke Eye Center were retrospectively reviewed. MGD was categorized using the degree of atrophy on meibographs. Immune analysis was done using high-parameter flow cytometry on tear samples. RESULTS: Compared with BM only, BM+T mice had higher systemic disease scores that correlated with tear fluid loss and eyelid edema. BM+T had higher immune cell infiltration in the ocular tissues and higher CD4+-cell cytokine expression in draining lymph nodes. BM+T mice with worse MGD scores had significantly worse corneal staining. In patients with ocular GVHD, 96% had other organs affected. Patients with ocular GVHD had abnormal parameters on dry eye testing, high matrix metalloproteinase-9 positivity (92%), and abundance of immune cells in tear samples. Ocular surface disease signs were worse in patients with higher MGD severity scores. CONCLUSIONS: Ocular GVHD is driven by a systemic, T-cell-dependent process that causes meibomian gland damage and induces a robust form of ocular surface disease that correlates with MGD severity. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Perez VL, Mousa HM, Soifer M, et al. Meibomian Gland Dysfunction: A Route of Ocular Graft-Versus-Host Disease Progression That Drives a Vicious Cycle of Ocular Surface Inflammatory Damage. Am J Ophthalmol. 2022. PMID: 36162534. doi:10.1016/j.ajo.2022.09.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。